Ning Shan

Person

Tampa, FL, US

People

Patents Grantslast 30 patents

Information Patent Grant
Crystalline form of s-apomorphine
- Patent number 11,459,301
- Issue date Oct 4, 2022
- Aclipse One, Inc.
- Ning Shan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sublingual opioid formulations containing naloxone
- Patent number 10,874,658
- Issue date Dec 29, 2020
- HIKMA PHARMACEUTICALS USA INC.
- Ning Shan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline forms
- Patent number 10,526,358
- Issue date Jan 7, 2020
- THAR PHARMA, LLC
- Mazen Hanna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline forms
- Patent number 10,519,176
- Issue date Dec 31, 2019
- THAR PHARMA, LLC
- Mazen Hanna
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystallization method and bioavailability
- Patent number 10,323,052
- Issue date Jun 18, 2019
- Grunenthal GmbH
- Mazen Hanna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sublingual opioid formulations containing naloxone
- Patent number 10,265,309
- Issue date Apr 23, 2019
- INSYS DEVELOPMENT COMPANY, INC.
- Ning Shan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystallization method and bioavailability
- Patent number 10,093,691
- Issue date Oct 9, 2018
- GRUNENTHAL GMBH
- Mazen Hanna
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oral forms of a phosphonic acid derivative
- Patent number 9,682,091
- Issue date Jun 20, 2017
- GRUNENTHAL GMBH
- Mazen Hanna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline forms
- Patent number 9,340,565
- Issue date May 17, 2016
- THAR PHARMACEUTICALS, INC.
- Mazen Hanna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystallization method and bioavailability
- Patent number 9,334,296
- Issue date May 10, 2016
- Thar Pharmaceuticals, Inc.
- Mazen Hanna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystallization method and bioavailability
- Patent number 9,169,279
- Issue date Oct 27, 2015
- Thar Pharmaceuticals, Inc.
- Mazen Hanna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline molecular comlpexes of tadalafil
- Patent number 9,040,535
- Issue date May 26, 2015
- Thar Pharmaceuticals, Inc.
- Mazen Hanna
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oral forms of a phosphonic acid derivative
- Patent number 8,980,868
- Issue date Mar 17, 2015
- Thar Pharmaceuticals, Inc.
- Mazen Hanna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystallization method and bioavailability
- Patent number 8,933,057
- Issue date Jan 13, 2015
- Thar Pharmaceuticals, Inc.
- Mazen Hanna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline molecular complex of tadalafil and methylparaben
- Patent number 8,586,587
- Issue date Nov 19, 2013
- Thar Pharmaceuticals, Inc.
- Mazen Hanna
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline forms of lamotrigine
- Patent number 8,486,927
- Issue date Jul 16, 2013
- Thar Pharmaceuticals
- Mazen Hanna
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystallization method and bioavailability
- Patent number 8,399,023
- Issue date Mar 19, 2013
- Thar Pharmaceuticals, Inc.
- Mazen Hanna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
In vivo studies of crystalline forms of meloxicam
- Patent number 8,389,512
- Issue date Mar 5, 2013
- Thar Pharmaceuticals
- Mazen Hanna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
In vivo studies of crystalline forms of meloxicam
- Patent number 8,124,603
- Issue date Feb 28, 2012
- Thar Pharmaceuticals
- Mazen Hanna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
TREATMENT OF KIDNEY DISEASES
- Publication number 20240180908
- Publication date Jun 6, 2024
- Ning Shan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF NEUROLOGICAL...
- Publication number 20230141988
- Publication date May 11, 2023
- Aclipse One Inc.
- Ning Shan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Compositions of (6aS)-6-methyl-5,6,6a,7-tetrahydro-4...
- Publication number 20220313682
- Publication date Oct 6, 2022
- Aclipse One Inc.
- Ning Shan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF NEUROLOGICAL DISEASE
- Publication number 20220265635
- Publication date Aug 25, 2022
- Aclipse One Inc.
- Richard James Mead
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF NEUROLOGICAL DISEASE
- Publication number 20210353613
- Publication date Nov 18, 2021
- Aclipse One Inc.
- Ning Shan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE FORM OF S-APOMORPHINE
- Publication number 20210214310
- Publication date Jul 15, 2021
- ACLIPSE ONE, INC.
- Ning SHAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBLINGUAL OPIOID FORMULATIONS CONTAINING NALOXONE
- Publication number 20190209540
- Publication date Jul 11, 2019
- Insys Development Company, Inc.
- Ning Shan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL CRYSTALLINE FORMS
- Publication number 20190144474
- Publication date May 16, 2019
- Grunenthal GmbH
- Mazen HANNA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL CRYSTALLINE FORMS
- Publication number 20190002483
- Publication date Jan 3, 2019
- Grunenthal GmbH
- Mazen HANNA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLIZATION METHOD AND BIOAVAILABILITY
- Publication number 20180333425
- Publication date Nov 22, 2018
- Grunenthal GmbH
- Mazen HANNA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBLINGUAL OPIOID FORMULATIONS CONTAINING NALOXONE
- Publication number 20170340620
- Publication date Nov 30, 2017
- Insys Development Company, Inc.
- Ning Shan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBLINGUAL FENTANYL FORMULATIONS CONTAINING A PERMEATION ENHANCER
- Publication number 20170340557
- Publication date Nov 30, 2017
- Insys Development Company, Inc.
- Ning Shan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL CRYSTALLINE FORMS
- Publication number 20170022225
- Publication date Jan 26, 2017
- Thar Pharmaceuticals, Inc.
- Mazen HANNA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLIZATION METHOD AND BIOAVAILABILITY
- Publication number 20170022227
- Publication date Jan 26, 2017
- Thar Pharmaceuticals, Inc.
- Mazen HANNA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLIZATION METHOD AND BIOAVAILABILITY
- Publication number 20170022226
- Publication date Jan 26, 2017
- Thar Pharmaceuticals, Inc.
- Mazen HANNA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBLINGUAL NALOXONE SPRAY
- Publication number 20160199294
- Publication date Jul 14, 2016
- Insys Development Company, Inc.
- Kiran Amancha
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLIZATION METHOD AND BIOAVAILABILITY
- Publication number 20160016982
- Publication date Jan 21, 2016
- Thar Pharmaceuticals, Inc.
- Mazen HANNA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL ORAL FORMS OF A PHOSPHONIC ACID DERIVATIVE
- Publication number 20150306116
- Publication date Oct 29, 2015
- Thar Pharmaceuticals, Inc.
- Mazen HANNA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLIZATION METHOD AND BIOAVAILABILITY
- Publication number 20140107076
- Publication date Apr 17, 2014
- Thar Pharmaceuticals, Inc.
- Mazen HANNA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALIZATION OF PHARMACEUTICAL COMPOUNDS
- Publication number 20140100233
- Publication date Apr 10, 2014
- Thar Pharmaceuticals, Inc.
- Mazen HANNA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLIZATION METHOD AND BIOAVAILABILITY
- Publication number 20140057875
- Publication date Feb 27, 2014
- Thar Pharmaceuticals, Inc.
- Mazen HANNA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL CRYSTALLINE FORMS
- Publication number 20130316982
- Publication date Nov 28, 2013
- Thar Pharmaceuticals, Inc.
- Mazen Hanna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLIZATION METHOD AND BIOAVAILABILITY
- Publication number 20130035315
- Publication date Feb 7, 2013
- Mazen HANNA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL ORAL FORMS OF A PHOSPHONIC ACID DERIVATIVE
- Publication number 20120190647
- Publication date Jul 26, 2012
- Mazen Hanna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
In Vivo Studies of Crystalline Forms of Meloxicam
- Publication number 20120149692
- Publication date Jun 14, 2012
- Thar Pharmaceuticals
- Mazen Hanna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALIZATION OF PHARMACEUTICAL COMPOUNDS
- Publication number 20120046297
- Publication date Feb 23, 2012
- Mazen Hanna
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLIZATION METHOD AND BIOAVAILABILITY
- Publication number 20110028435
- Publication date Feb 3, 2011
- Thar Pharmaceuticals, Inc.
- Mazen HANNA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
In vivo studies of crystalline forms of meloxicam
- Publication number 20090203680
- Publication date Aug 13, 2009
- Thar Pharmaceuticals
- Mazen Hanna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Crystalline Forms of lamotrigine
- Publication number 20090176787
- Publication date Jul 9, 2009
- Thar Pharmaceuticals
- Mazen Hanna
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Crystalline form of s-apomorphine

Sublingual opioid formulations containing naloxone

Crystalline forms

Crystalline forms

Crystallization method and bioavailability

Sublingual opioid formulations containing naloxone

Crystallization method and bioavailability

Oral forms of a phosphonic acid derivative

Crystalline forms

Crystallization method and bioavailability

Crystallization method and bioavailability

Crystalline molecular comlpexes of tadalafil

Oral forms of a phosphonic acid derivative

Crystallization method and bioavailability

Crystalline molecular complex of tadalafil and methylparaben

Crystalline forms of lamotrigine

Crystallization method and bioavailability

In vivo studies of crystalline forms of meloxicam

In vivo studies of crystalline forms of meloxicam

Patents Applicationslast 30 patents

TREATMENT OF KIDNEY DISEASES

PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF NEUROLOGICAL...

Pharmaceutical Compositions of (6aS)-6-methyl-5,6,6a,7-tetrahydro-4...

TREATMENT OF NEUROLOGICAL DISEASE

TREATMENT OF NEUROLOGICAL DISEASE

CRYSTALLINE FORM OF S-APOMORPHINE

SUBLINGUAL OPIOID FORMULATIONS CONTAINING NALOXONE

NOVEL CRYSTALLINE FORMS

NOVEL CRYSTALLINE FORMS

CRYSTALLIZATION METHOD AND BIOAVAILABILITY

SUBLINGUAL OPIOID FORMULATIONS CONTAINING NALOXONE

SUBLINGUAL FENTANYL FORMULATIONS CONTAINING A PERMEATION ENHANCER

NOVEL CRYSTALLINE FORMS

CRYSTALLIZATION METHOD AND BIOAVAILABILITY

CRYSTALLIZATION METHOD AND BIOAVAILABILITY

SUBLINGUAL NALOXONE SPRAY

CRYSTALLIZATION METHOD AND BIOAVAILABILITY

NOVEL ORAL FORMS OF A PHOSPHONIC ACID DERIVATIVE

CRYSTALLIZATION METHOD AND BIOAVAILABILITY

CRYSTALIZATION OF PHARMACEUTICAL COMPOUNDS

CRYSTALLIZATION METHOD AND BIOAVAILABILITY

NOVEL CRYSTALLINE FORMS

CRYSTALLIZATION METHOD AND BIOAVAILABILITY

NOVEL ORAL FORMS OF A PHOSPHONIC ACID DERIVATIVE

In Vivo Studies of Crystalline Forms of Meloxicam

CRYSTALIZATION OF PHARMACEUTICAL COMPOUNDS

CRYSTALLIZATION METHOD AND BIOAVAILABILITY

In vivo studies of crystalline forms of meloxicam

Crystalline Forms of lamotrigine